1-3 of 3
Xavier Fund
Close
Sort by
Journal Articles

A Novel Metabolic Transcriptome Identified in Myelodysplastic Syndromes (MDS) Correlates with OMS Classification and Poor Prognosis

Christophe Desterke, Estelle Balducci, Xavier Fund, Claire Borie, Annelise Bennaceur-Griscelli, MD PhD, Ali G Turhan, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5495.
https://doi.org/10.1182/blood-2018-99-110678
Published: 2018
Journal Articles

Cartridge-Based Automated BCR-ABL mRNA Quantification: Towards Simplified Standardisation.

Jean-Michel Cayuela, PhD, PharmD, Elizabeth Macintyre, MD, PhD, Meryl Darlington, Raouf Ben Abdelali, MD, Xavier Fund, Patrick Villarè€se, William Piterboth, Michel Tulliez, MD, Emmanuel Raffoux, MD, Francois Sigaux, MD, PhD, Delphine Rea, MD, PhD, Dominique Bories, MD, PhD, Valerie Seror
Journal: Blood
Blood (2009) 114 (22): 4261.
https://doi.org/10.1182/blood.V114.22.4261.4261
Published: 2009
Journal Articles

Evaluation of Minimal Residual Disease (MRD) by Quantification of TEL-AML1 Transcripts Is a Powerful Prognostic Tool in Children with T(12;21) Positive Acute Lymphoblastic Leukemia (ALL).

Jean-Michel Cayuela, PhD, Paola Ballerini, PhD, Marina Romeo, PhD, Vahid Asnafi, PhD, Marie-Francoise Auclerc, MD, Xavier Fund, PhD, Eric Delabesse, PhD, Christian Bastard, PhD, Jean Gabert, PhD, Jean-Pierre Vanier, MD, Odile Lejars, MD, Mariane Debre, MD, Brigitte Pautard, MD, Gerard Michel, MD, Thierry Leblanc, MD, Guy Leverger, MD, Sylvie Chevret, PhD, Elisabeth Macintyre, PhD, Andre Baruchel, MD, for the FRALLE group
Journal: Blood
Blood (2004) 104 (11): 322.
https://doi.org/10.1182/blood.V104.11.322.322
Published: 2004